Extracellular matrix (ECM) biomarkers are elevated in advanced renal cell carcinoma (aRCC) and predictive of response to nivolumab plus ipilimumab (NIVO+IPI): Analysis from CheckMate 214 Meeting Abstract


Authors: Gupta, S.; Han, C.; Dwivedi, B.; Li, J.; Karsdal, M.; Motzer, R.; Willumsen, N.; McDermott, D.; Choueiri, T.
Abstract Title: Extracellular matrix (ECM) biomarkers are elevated in advanced renal cell carcinoma (aRCC) and predictive of response to nivolumab plus ipilimumab (NIVO+IPI): Analysis from CheckMate 214
Meeting Title: 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 10
Issue: Suppl. 2
Meeting Dates: 2022 Nov 8-12
Meeting Location: Boston, MA
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2022-11-01
Start Page: A581
Language: English
ACCESSION: WOS:000919423400523
DOI: 10.1136/jitc-2022-SITC2022.0556
PROVIDER: wos
Notes: Meeting Abstract: 556 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer